Eric Casaburi
About Eric Casaburi
Eric Casaburi, age 51, is a Class I director of OneMedNet, serving since November 2023 with his term expiring at the 2027 annual meeting; the Board has determined he is independent under Nasdaq and SEC rules . He is an experienced entrepreneur who founded and scaled RetroFitness to approximately $150 million in annual sales, and has led multiple franchise and consumer brands with successful investor exits . Since 2021, he has been founder and CEO of Serotonin Enterprises LLC (anti-aging health optimization), and since 2019 he has chaired TIGER 21 Orlando, alongside operating Longevity Brands (since 2020) and CEVD Holdings (since 2016) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| RetroFitness | Founder & CEO | Not disclosed | Built national footprint; scaled to ~$150M revenue |
| Lets YO! Yogurt | Founder & CEO | 2012–2015 | Franchised model; 24 restaurants opened in year one; exited to PE firm |
| CEVD Holdings | Owner (commercial real estate investment/management) | Since 2016 | Sales/ops systems development across ventures |
| Longevity Brands | Founder/Operator | Since 2020 | Operated wellness/health portfolio |
| Serotonin Enterprises LLC | Founder & CEO | Since 2021 | Anti-aging health optimization franchise; featured in Franchise Times |
| TIGER 21 Orlando | Chair | Since 2019 | Peer learning group focused on wealth management transition |
External Roles
| Organization | Sector | Role | Notes |
|---|---|---|---|
| Serotonin Enterprises LLC | Health optimization | Founder & CEO | Franchise model; broad wellness services |
| TIGER 21 Orlando | Peer investing network | Chair | Group focused on wealth stewardship |
| Longevity Brands | Health/wellness | Founder/Operator | Portfolio operations |
| CEVD Holdings | Real estate | Owner | Commercial real estate investment/management |
Board Governance
- Independence: The Board determined Casaburi is independent; ONMD’s Board has a majority of independent directors .
- Committee assignments: Chair, Nominating & Corporate Governance Committee; not a member of Audit or Compensation .
- Committee activity: In 2024, Nominating & Corporate Governance met 2 times; Audit met 4; Compensation met 1 .
- Attendance: In 2024 the Board held 2 meetings, and no director attended fewer than 75% of Board and applicable committee meetings; four directors attended the 2024 annual meeting .
- Board leadership and risk oversight: Chair is separate from CEO; independent directors meet in executive session each regular Board meeting; committee-level risk oversight includes Audit for cybersecurity/financial reporting, Compensation for compensation risk, and Nominating for independence/conflict oversight .
Fixed Compensation
| Component (USD / Units) | FY 2024 |
|---|---|
| Annual cash retainer | $0 |
| Equity grant (policy) | 45,000 RSUs per full year of service |
| Equity grant (fair value recognized) | $19,350 |
| Meeting/committee fees | $0 |
| Expense reimbursement | Reasonable out-of-pocket expenses reimbursed (no amounts disclosed) |
Performance Compensation
| Performance Metric | FY 2024 Treatment |
|---|---|
| Performance-based equity (PSUs) | None disclosed for directors |
| Cash bonuses tied to metrics | None disclosed for directors |
| Specific targets (revenue, EBITDA, TSR, ESG) | Not disclosed for directors |
Other Directorships & Interlocks
| Company | Exchange | Role | Interlock/Conflict Notes |
|---|---|---|---|
| None disclosed | — | — | No current public company directorships disclosed for Casaburi |
Expertise & Qualifications
- Serial founder/operator across franchising, health/wellness, food services, and real estate; history of rapid scaling and investor exits .
- Developed sales, operations, and marketing systems; diversified recurring revenue models .
Equity Ownership
| Holder | As of Date | Shares Beneficially Owned | Percent of Class |
|---|---|---|---|
| Eric Casaburi | Oct 23, 2025 | 65,475 | <1% |
- Methodology includes RSUs vesting within 60 days in beneficial ownership calculations generally; no vested/unvested breakdown provided for Casaburi .
- Hedging/pledging: Insider Trading Policy prohibits hedging and pledging transactions for directors and officers .
Governance Assessment
- Positive indicators:
- Independent director; majority-independent Board .
- Chair of Nominating & Corporate Governance, aligning with oversight of board effectiveness and conflicts .
- Director compensation structure emphasizes equity (RSUs) with no cash retainer, aligning incentives with shareholder value .
- Executive sessions of independent directors and clear committee risk oversight .
- No related-person transactions disclosed involving Casaburi in 2023–2025 review .
- Watch items / red flags to monitor:
- Low direct ownership (<1%); while typical for small-cap boards, alignment depends on ongoing equity grants and holding practices .
- Director equity awards appear service-based RSUs with no disclosed performance metrics (PSUs/targets), which may reduce pay-for-performance rigor for directors .
- Board/committee attendance disclosed in aggregate; individual attendance percentages not detailed (company notes no director below 75%) .
No evidence of conflicts, related-party exposure, pledging, or hedging by Casaburi was disclosed; continued monitoring of any business dealings between ONMD and Casaburi-affiliated entities (Serotonin, Longevity Brands, CEVD Holdings) is prudent given sector adjacency, though none are reported .